207 related articles for article (PubMed ID: 16439074)
1. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs.
Venkatesan N; Yoshimitsu J; Ohashi Y; Ito Y; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Mar; 310(1-2):46-52. PubMed ID: 16439074
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
Ito Y; Shiroyama K; Yoshimitsu J; Ohashi Y; Sugioka N; Takada K
J Control Release; 2007 Aug; 121(3):176-80. PubMed ID: 17628163
[TBL] [Abstract][Full Text] [Related]
3. Gastro-intestinal patch system for the delivery of erythropoietin.
Venkatesan N; Uchino K; Amagase K; Ito Y; Shibata N; Takada K
J Control Release; 2006 Mar; 111(1-2):19-26. PubMed ID: 16377018
[TBL] [Abstract][Full Text] [Related]
4. Effect of fiber length of carbon nanotubes on the absorption of erythropoietin from rat small intestine.
Ito Y; Venkatesan N; Hirako N; Sugioka N; Takada K
Int J Pharm; 2007 Jun; 337(1-2):357-60. PubMed ID: 17270373
[TBL] [Abstract][Full Text] [Related]
5. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics.
Venkatesan N; Yoshimitsu J; Ito Y; Shibata N; Takada K
Biomaterials; 2005 Dec; 26(34):7154-63. PubMed ID: 15967493
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
Yoon WH; Park SJ; Kim IC; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
Melo AM; Costa MT; Porta V; Vaz FA
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
[TBL] [Abstract][Full Text] [Related]
8. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion.
Zheng JY; Fulu MY
Int J Pharm; 2006 Jan; 307(2):209-15. PubMed ID: 16300912
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies.
Ito Y; Kusawake T; Prasad YV; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Jul; 317(2):114-9. PubMed ID: 16631328
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the toxicity of novel Zn-DTPA tablet formulation in dogs and rats.
Shankar GN; Potharaju S; Green CE
Drug Dev Res; 2014 Feb; 75(1):37-46. PubMed ID: 24648048
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
13. [Mucoadhesive oral tablets--a modern dosage form with controlled drug release].
Dostálová M; Rabisková M
Ceska Slov Farm; 2000 Mar; 49(2):55-61. PubMed ID: 10953444
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
Liu H; Pan W; Ke P; Dong Y; Ji L
Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.
Woo S; Krzyzanski W; Jusko WJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1297-306. PubMed ID: 16973883
[TBL] [Abstract][Full Text] [Related]
16. Distribution characteristics of entrapped recombinant human erythropoietin in liposomes and its intestinal absorption in rats.
Maitani Y; Moriya H; Shimoda N; Takayama K; Nagai T
Int J Pharm; 1999 Aug; 185(1):13-22. PubMed ID: 10425361
[TBL] [Abstract][Full Text] [Related]
17. Self-dissolving micropile array chip as percutaneous delivery system of protein drug.
Ito Y; Hasegawa R; Fukushima K; Sugioka N; Takada K
Biol Pharm Bull; 2010; 33(4):683-90. PubMed ID: 20410606
[TBL] [Abstract][Full Text] [Related]
18. Absorption of interferon alpha from patches in rats.
Ito Y; Tosh B; Togashi Y; Amagase K; Kishida T; Kishida T; Sugioka N; Shibata N; Takada K
J Drug Target; 2005 Jul; 13(6):383-90. PubMed ID: 16278158
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
20. Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability.
Maitani Y; Hazama M; Tojo Y; Shimoda N; Nagai T
J Pharm Sci; 1996 Apr; 85(4):440-5. PubMed ID: 8901085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
